<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="41ccafc0-c701-4321-868d-cbaf3f5a8df2"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Jacqueline du Pré</title>
  <effectiveTime value="20260323120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="5c2a468a-5b8e-450d-b2f3-78d5e9a02b49"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="a616df5f-7768-413c-a23b-75c6fd159a8d" extension="HR-ML039-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-39-7062"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Jacqueline</given><given>Mary</given><family>du Pré</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19980126"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260323120000-0500"/>
    <assignedAuthor><id root="8e9aaa57-cf30-4755-941b-9965e76ad9c3"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Imogen</given><family>Thackeray-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260323120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="8e9aaa57-cf30-4755-941b-9965e76ad9c3"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Imogen</given><family>Thackeray-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="8e9aaa57-cf30-4755-941b-9965e76ad9c3"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Imogen</given><family>Thackeray-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="5ea2e13a-8643-4f62-bc36-697fa6c8c50b"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Diagnosis of relapsing-remitting multiple sclerosis: neurology consultation, treatment of the relapse, choice of high-efficacy disease-modifying therapy, and vaccinations before B-cell therapy</originalText></code>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="8e9aaa57-cf30-4755-941b-9965e76ad9c3"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Imogen</given><family>Thackeray-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Diagnosis visit: MRI and lumbar puncture results and the neurology consultation. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. du Pré returns two weeks after her first visit. MRI of the brain and spine three days after that visit showed lesions typical of multiple sclerosis in the brain and the spinal cord, including an enhancing lesion at C3 to C4 that explains her hands, and the lumbar puncture a week ago showed oligoclonal bands in the spinal fluid only. Aquaporin-4 antibody was negative. She was seen today by Dr. Lindgren-Achebe. The numbness and clumsiness in her fingers are no better; she has practiced for only a few minutes at a time this week and has cancelled two more concerts. The electric feeling down her back when she bends her head continues. She is tired by mid-afternoon. She asked what multiple sclerosis will mean for her playing, and whether she can still have children. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Diagnosis</td><td>Relapsing-remitting multiple sclerosis, active: dissemination in space and time on MRI and CSF-specific oligoclonal bands</td></tr><tr><td>Tests since the first visit</td><td>MRI of the brain and cervical and thoracic spine with gadolinium; lumbar puncture; aquaporin-4 antibody; HIV and syphilis serology</td></tr><tr><td>Symptoms</td><td>Numb, clumsy fingers, worse on the left; Lhermitte&apos;s sign; fatigue</td></tr><tr><td>Her questions</td><td>Whether she will play again; whether she can have children; how treatment will fit around concerts and teaching</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Positive</td><td>Tired by mid-afternoon; no fever; weight steady</td></tr><tr><td>Neurological</td><td>Positive</td><td>Numbness and clumsiness of the fingers; Lhermitte&apos;s sign; no weakness of the legs, imbalance or visual change</td></tr><tr><td>Genitourinary</td><td>Negative</td><td>No urinary urgency or burning; last period three weeks ago</td></tr><tr><td>Eyes</td><td>Negative</td><td>No blurred vision or pain on moving the eyes</td></tr><tr><td>Musculoskeletal</td><td>Negative</td><td>No back pain</td></tr><tr><td>Psychiatric</td><td>Positive</td><td>Frightened and tearful about her playing; PHQ-9 7, GAD-7 6; no thoughts of self-harm</td></tr></tbody></table><paragraph>6 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-3"><td>Cholecalciferol (vitamin D3) 4000 unit (100 microgram) oral capsule, one capsule by mouth daily</td><td>One capsule daily</td><td>Oral route</td><td>2026-03-23</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="f97c6ecd-6428-4534-bc77-f92fe068dc05"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1092380" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.1 MG Oral Capsule"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e7a4c2dd-0c18-4e28-a576-619cd4459a6f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="7c188938-b388-44b1-b2b2-824327e62ec7"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="54d3f8c0-eaf6-4706-b18f-93c27eec4d31"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>2026-03-23</td><td>Body height</td><td>173</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>2026-03-23</td><td>Body weight</td><td>63.4</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>2026-03-23</td><td>Body mass index (BMI) [Ratio]</td><td>21.2</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>2026-03-23</td><td>Systolic blood pressure</td><td>114</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>2026-03-23</td><td>Diastolic blood pressure</td><td>72</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>2026-03-23</td><td>Heart rate</td><td>76</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>2026-03-23</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>2026-03-23</td><td>Body temperature</td><td>36.7</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>2026-03-23</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>99</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="04c09da0-d906-406b-b7ae-b9662b9b21e3"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260323"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="fad5a102-f9dc-4266-92bc-f34638b09bc8"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="173" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="24d76f56-afce-427d-81da-29a4006e443a"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="63.4" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="3afca607-dc27-4d82-99d4-1c191204b3a1"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="21.2" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f6aba87d-b8d5-4f38-adf3-f06d2091742e"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="114" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="098fe6dc-3e57-4e93-98aa-b37dff69b160"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="72" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="16763632-e756-412e-b1ef-2ed5f1a9d2dc"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="76" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="2a7e71b4-0274-4bc9-a56f-56fd23fb1169"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="4bec74f6-efea-435f-9ee3-7382840132f5"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="36.7" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ca86a86a-6c70-4301-9593-47528c0a5290"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="99" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-17"><td>2026-03-23</td><td>25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma</td><td>16</td><td>ng/mL</td><td>Below 20 ng/mL deficient; 20 to 29 insufficient</td><td>Low</td><td>S</td></tr>
  <tr ID="result-18"><td>2026-03-23</td><td>IgG [Mass/volume] in Serum or Plasma</td><td>1080</td><td>mg/dL</td><td>700-1600 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-19"><td>2026-03-23</td><td>IgM [Mass/volume] in Serum or Plasma</td><td>124</td><td>mg/dL</td><td>40-230 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-20"><td>2026-03-23</td><td>Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]</td><td>7</td><td>{score}</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-21"><td>2026-03-23</td><td>Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]</td><td>6</td><td>{score}</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-22"><td>2026-03-23</td><td>9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]</td><td>24.5</td><td>s</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-23"><td>2026-03-23</td><td>9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]</td><td>31</td><td>s</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="faef8e84-cb76-4798-b208-cbe08004f398"/>
      <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="bdac76d8-c5cc-40dd-b9e9-8a7ba0841ad5"/>
          <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-17"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="16" unit="ng/mL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>Below 20 ng/mL deficient; 20 to 29 insufficient</text>
              <value xsi:type="IVL_PQ"><low value="20" unit="ng/mL"/><high value="100" unit="ng/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="b73b2eb8-5638-4f63-aaf0-842a8421368b"/>
      <code code="2465-3" codeSystem="2.16.840.1.113883.6.1" displayName="IgG [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="360994a5-1ea7-430f-95da-b64edb6de5e4"/>
          <code code="2465-3" codeSystem="2.16.840.1.113883.6.1" displayName="IgG [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-18"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="1080" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>700-1600 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="700" unit="mg/dL"/><high value="1600" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="91530cfb-bf35-4f59-8f57-637318802077"/>
      <code code="2472-9" codeSystem="2.16.840.1.113883.6.1" displayName="IgM [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="dc06e99c-122f-43a8-9c32-7a90a43975df"/>
          <code code="2472-9" codeSystem="2.16.840.1.113883.6.1" displayName="IgM [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-19"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="124" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>40-230 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="40" unit="mg/dL"/><high value="230" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="d6ff3097-d797-4a05-b84e-4b04e294ccf0"/>
      <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="0d42c702-fba2-48bf-8b15-46e34335e9ae"/>
          <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
          <text><reference value="#result-20"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="7" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3be8dd24-4916-47ae-b518-d52ef41d2123"/>
      <code code="70274-6" codeSystem="2.16.840.1.113883.6.1" displayName="Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="0bdeec0a-7ecf-4240-84c2-c69504922c74"/>
          <code code="70274-6" codeSystem="2.16.840.1.113883.6.1" displayName="Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]"/>
          <text><reference value="#result-21"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="6" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="84b609cc-0696-46d9-8b83-caf7fb304ab2"/>
      <code code="83157-8" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="4498d24c-83a6-4e1d-958e-58bb8eb3cc14"/>
          <code code="83157-8" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]"/>
          <text><reference value="#result-22"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="24.5" unit="s"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="370c1fae-2a97-4ea9-a1ab-1b10764df048"/>
      <code code="83156-0" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="542959a5-672c-484d-a14a-96c3429bb603"/>
          <code code="83156-0" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]"/>
          <text><reference value="#result-23"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="31" unit="s"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-03-23; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; weight 63.4 kg; blood pressure 114/72, pulse 76</td></tr><tr><td>Cranial nerves</td><td>Normal; no nystagmus; visual acuity and fields normal</td></tr><tr><td>Neurological</td><td>Reduced vibration and joint position sense in the fingers of both hands, worse on the left, with mild wandering of the left fingers when the eyes are closed; light touch reduced in the fingertips; finger and wrist strength 5 out of 5 except finger abduction 4+ on the left; brisk reflexes in the arms; Lhermitte&apos;s sign present; gait and balance normal. Nine-hole peg test 24.5 seconds right, 31.0 seconds left. EDSS 2.0</td></tr><tr><td>Psychiatric</td><td>Warm and expressive; anxious; asks exact questions</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Numbness, tingling and loss of position sense in the fingers of both hands for three weeks, worse on the left, with clumsiness that makes her lose her place on the fingerboard, an electric feeling down the spine on bending the neck (Lhermitte&apos;s sign), and fatigue; a similar month of tingling in the fingers 18 months ago settled on its own. A lesion of the cervical spinal cord must be found: MRI of the brain and spine with contrast booked this week</td><td>resolved</td><td>confirmed</td>
    <td>R20.2</td><td>S — Synthetic presenting problem anchored to her documented loss of sensation in her fingers and fatigue. Superseded by the diagnosis at the second visit.</td>
  </tr>
  <tr ID="problem-2">
    <td>Relapsing-remitting multiple sclerosis, active: a current relapse (partial cervical myelitis at C3 to C4 with sensory loss and clumsiness of the hands) after an earlier sensory episode; dissemination in space and time on MRI, with an enhancing cord lesion and an enhancing brain lesion; CSF-specific oligoclonal bands; aquaporin-4 antibody negative; meets the 2017 McDonald criteria and the 2024 revision; synthetic modern detail linked to her documented diagnosis</td><td>active</td><td>confirmed</td>
    <td>G35.A</td><td>S — Synthetic course, imaging and laboratory detail; linked to her documented diagnosis in October 1973.</td>
  </tr>
  <tr ID="problem-3">
    <td>Vitamin D deficiency: 25-hydroxyvitamin D 16 ng/mL; replacement to correct the deficiency, not as a treatment for multiple sclerosis</td><td>active</td><td>confirmed</td>
    <td>E55.9</td><td>S — Synthetic finding.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="e3d10112-7347-4227-89bd-2661888f97b9"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="cbaacce4-1d4f-4845-a8f5-cedcbac25520"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="R20.2" codeSystem="2.16.840.1.113883.6.90" displayName="Paresthesia of skin"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b2cdd90a-ff33-41aa-aa91-b570324c95ed"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="bca9c88d-8952-4418-9f6a-49aef781539c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="G35.A" codeSystem="2.16.840.1.113883.6.90" displayName="Relapsing-remitting multiple sclerosis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="11c98afd-5c8f-4696-8118-87b7f403eb61"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="ad41a5f8-becb-4b34-8002-3976438707b0"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Relapsing-remitting multiple sclerosis, active (G35.A)</content>. Multiple sclerosis by the 2017 McDonald criteria: a current attack (partial cervical myelitis) with an earlier sensory episode in the history, dissemination in space (periventricular, juxtacortical, infratentorial and spinal cord lesions) and in time (enhancing and non-enhancing lesions together), with CSF-specific oligoclonal bands. The 2024 revision is also met, and most lesions show a central vein. Mimics were excluded: vitamin B12 and TSH were normal, aquaporin-4 antibody was negative, and HIV and syphilis serology were negative. MOG antibody was not tested, because nothing suggests MOG antibody disease (no optic neuritis, no long cord lesion, no ADEM-like picture). The relapse limits her hand function and her work, so high-dose steroids are offered. With active disease at 28, Dr. Lindgren-Achebe and she chose early high-efficacy therapy: ocrelizumab, over natalizumab because her JCV antibody is positive (index 1.4) with a higher risk of PML after two years, and over ofatumumab because she prefers two infusions a year to monthly injections when she travels. [S]<list><item>Methylprednisolone 1 g intravenously daily for 3 days from tomorrow; urine dipstick negative today.</item><item>Ocrelizumab 300 mg on day 1 in three weeks and on day 15, then 600 mg every six months.</item><item>PCV20, recombinant zoster dose 1 and hepatitis B dose 1 today, at least two weeks before the first infusion.</item><item>Occupational therapy for hand function and fatigue next week; MS specialist nurse contact.</item></list></item><item><content styleCode="Bold">Vitamin D deficiency (E55.9)</content>. 25-hydroxyvitamin D 16 ng/mL. Replaced to correct the deficiency; it is not a treatment for multiple sclerosis. [S]<list><item>Cholecalciferol 4000 units daily.</item><item>Level in about three months.</item></list></item><item><content styleCode="Bold">Numbness and clumsiness of the hands with Lhermitte&apos;s sign (R20.2)</content>. Explained by the diagnosis made today; superseded. [S]<list><item>Problem resolved.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Imaging</td><td>MRI of the brain and cervical and thoracic spine with gadolinium</td><td>At diagnosis</td><td>Up to date</td><td>Eleven typical brain lesions in periventricular, juxtacortical and infratentorial sites, one enhancing; enhancing C3 to C4 lesion and non-enhancing T7 lesion; central veins in most lesions</td></tr><tr><td>Laboratory</td><td>Cerebrospinal fluid: oligoclonal bands, cell count, protein</td><td>At diagnosis when it adds certainty</td><td>Up to date</td><td>Six CSF-specific oligoclonal bands; IgG index 0.86; white cells 6, protein 42 mg/dL</td></tr><tr><td>Laboratory</td><td>Mimics: vitamin B12, TSH, HIV, syphilis</td><td>At diagnosis</td><td>Up to date</td><td>B12 468 pg/mL and TSH 1.6 mIU/L at the first visit; HIV and syphilis negative</td></tr><tr><td>Laboratory</td><td>Aquaporin-4 antibody (cell-based assay)</td><td>When a myelitis or optic neuritis raises neuromyelitis optica spectrum disorder</td><td>Up to date</td><td>Negative</td></tr><tr><td>Laboratory</td><td>MOG antibody</td><td>Only when the picture suggests MOG antibody disease</td><td>Not indicated</td><td>No optic neuritis, long cord lesion or ADEM-like picture; typical MS lesions with central veins</td></tr><tr><td>Laboratory</td><td>JCV antibody</td><td>Before choosing natalizumab, and every six months while on it</td><td>Up to date</td><td>Positive, index 1.4 (drawn with the lumbar puncture); natalizumab not chosen</td></tr><tr><td>Laboratory</td><td>Hepatitis B (surface antigen, core antibody, surface antibody), varicella and measles immunity</td><td>Before anti-CD20 therapy</td><td>Up to date</td><td>Drawn with the lumbar puncture: hepatitis B surface antigen and core antibody negative, surface antibody negative (not immune); varicella IgG positive; measles immune by two recorded doses</td></tr><tr><td>Laboratory</td><td>Immunoglobulins (IgG, IgM)</td><td>At baseline and before each ocrelizumab dose</td><td>Completed today</td><td>IgG 1080 mg/dL, IgM 124 mg/dL</td></tr><tr><td>Laboratory</td><td>25-hydroxyvitamin D</td><td>At diagnosis</td><td>Completed today</td><td>16 ng/mL: deficient</td></tr><tr><td>Laboratory</td><td>Pregnancy test</td><td>Before steroids and before each ocrelizumab dose</td><td>Completed today</td><td>Urine pregnancy test negative</td></tr><tr><td>Medication safety</td><td>Infection screen before high-dose steroids</td><td>Before each steroid course</td><td>Completed today</td><td>Urine dipstick negative; no fever</td></tr><tr><td>Medication safety</td><td>Vaccinations before B-cell therapy</td><td>Inactivated vaccines at least two weeks before the first dose; live vaccines at least four weeks before</td><td>Completed today</td><td>PCV20, recombinant zoster dose 1 and hepatitis B dose 1 given today; no live vaccine needed</td></tr><tr><td>Examination</td><td>Hand function: nine-hole peg test, both hands</td><td>At diagnosis, after a relapse, and at each review</td><td>Completed today</td><td>24.5 seconds right, 31.0 seconds left (typical for her age about 17 to 19 seconds)</td></tr><tr><td>Examination</td><td>Neurological examination and EDSS</td><td>At diagnosis and at each review</td><td>Completed today</td><td>Sensory loss in the fingers, mild left finger weakness, Lhermitte&apos;s sign; EDSS 2.0</td></tr><tr><td>Referral</td><td>Occupational therapy</td><td>For any problem with hand function or fatigue</td><td>Referred</td><td>Assessment booked for next week</td></tr><tr><td>Survey</td><td>Mood and anxiety (PHQ-9, GAD-7)</td><td>At diagnosis and at each review</td><td>Completed today</td><td>PHQ-9 7 (item 9 scored 0), GAD-7 6</td></tr><tr><td>Self-management</td><td>Pregnancy planning and contraception</td><td>At diagnosis and at each review</td><td>Completed today</td><td>Pregnancy is possible with multiple sclerosis; on ocrelizumab, conception is best planned a few months after a dose, with the neurologist; condoms for now</td></tr><tr><td>Self-management</td><td>Written information and MS specialist nurse</td><td>At diagnosis</td><td>Completed today</td><td>Written information given; nurse contact and relapse line</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>MRI of the brain and spine within one week and a neurology diagnosis within three weeks. Outcome by 2026-03-23: MRI in three days, lumbar puncture in a week, diagnosis and consultation at two weeks [S]</item><item>High-efficacy disease-modifying therapy started within six weeks of diagnosis, after screening and vaccinations. In progress; target 2026-04-27 [S]</item><item>Nine-hole peg times back to within 10 percent of normal in both hands, and full practice resumed. In progress; target 2026-07-13 [S]</item><item>No evidence of disease activity at six months (no relapse, no new or enhancing MRI lesion, no disability progression). In progress; target 2026-10-12 [S]</item><item>25-hydroxyvitamin D of 30 ng/mL or more. In progress; target 2026-07-13 [S]</item><item>PHQ-9 below 10 throughout. In progress; target 2026-10-12 [S]</item></list><paragraph>Immunizations given today: Pneumococcal conjugate vaccine (PCV20), before B-cell therapy; Recombinant zoster vaccine, dose 1 of 2, before B-cell therapy; Hepatitis B vaccine (adjuvanted, two-dose series), dose 1, before B-cell therapy [S]</paragraph><paragraph>Guideline basis: Rae-Grant A, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis. Neurology 2018;90(17):777-788 (PMID 29686116) (2018); Montalban X, et al. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 2018;24(2):96-120 (PMID 29353550) (2018); Multiple sclerosis in adults: management (NICE guideline NG220) (2022); Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162-173 (PMID 29275977) (2017); Montalban X, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 2025;24(10):850-865 (doi:10.1016/S1474-4422(25)00270-4) (2025); Wattjes MP, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol 2021;20(8):653-670 (PMID 34139157) (2021); Farez MF, et al. Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis. Neurology 2019;93(13):584-594 (PMID 31462584) (2019)</paragraph><paragraph>Follow-up: Methylprednisolone from tomorrow for 3 days; occupational therapy next week; ocrelizumab day 1 in three weeks. Review at the second half-dose. Call at once for new weakness, imbalance, loss of vision or bladder control. Next scheduled visit 2026-04-27: second half-dose of the first ocrelizumab course: recovery of hand function, infusion reactions, vaccination, practice and work. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
